Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.670
-0.170 (-9.24%)
At close: Apr 29, 2026, 4:00 PM EDT
1.690
+0.020 (1.20%)
After-hours: Apr 29, 2026, 7:59 PM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $300.75 million as of April 29, 2026. Its market cap has increased by 28.31% in one year.
Market Cap
300.75M
Enterprise Value
101.67M
1-Year Change
28.31%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $300.75M, a decrease of -30.92%. That is a compound annual growth rate of -7.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 331.36M | -65.31% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 357.01M |
| Armata Pharmaceuticals | 355.70M |
| Immuneering | 348.72M |
| Surrozen | 348.10M |
| DiaMedica Therapeutics | 336.77M |
| Palisade Bio | 332.34M |
| Bicycle Therapeutics | 329.02M |
| Nautilus Biotechnology | 327.80M |